Arcturus Therapeutics Ltd. Operating Expenses
Arcturus Therapeutics Ltd. reported Operating Expenses of $10.86 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-05-13
- Arcturus Therapeutics Ltd. operating expenses for the quarter ending 2019-03-31 was $10.86M, a 20.12% increase year-over-year.
- Arcturus Therapeutics Ltd. operating expenses for the quarter ending 2018-12-31 was $8.29M, a 18.62% increase year-over-year.
- Arcturus Therapeutics Ltd. operating expenses for the quarter ending 2018-09-30 was $7.78M, a 21.38% increase year-over-year.
- Arcturus Therapeutics Ltd. operating expenses for the quarter ending 2018-06-30 was $12.46M, a 158.09% increase year-over-year.
- Arcturus Therapeutics Ltd. operating expenses for fiscal 2018 was $37.56M, a 59.91% increase from fiscal 2017.
- Arcturus Therapeutics Ltd. operating expenses for fiscal 2017 was $23.49M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2019-03-31 | $10.86M 10-Q · filed 2019-05-13 | $19.15M derived: sum of 2 quarters · filed 2019-05-13 | $26.93M derived: sum of 3 quarters · filed 2019-05-13 | $39.38M derived: sum of 4 quarters · filed 2019-05-13 |
| 2018-12-31 | $8.29M derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $16.07M derived: sum of 2 quarters · filed 2019-03-18 | $28.52M derived: sum of 3 quarters · filed 2019-03-18 | $37.56M 10-K · filed 2019-03-18 |
| 2018-09-30 | $7.78M 6-K · filed 2018-11-07 | $20.24M derived: sum of 2 quarters · filed 2018-11-07 | $29.28M 6-K · filed 2018-11-07 | $36.26M derived: sum of 4 quarters · filed 2019-05-13 |
| 2018-06-30 | $12.46M 6-K · filed 2018-09-28 | $21.50M 6-K · filed 2018-09-28 | $28.48M derived: sum of 3 quarters · filed 2019-05-13 | $34.89M derived: sum of 4 quarters · filed 2019-05-13 |
| 2018-03-31 | $9.04M 10-Q · filed 2019-05-13 | $16.03M derived: sum of 2 quarters · filed 2019-05-13 | $22.43M derived: sum of 3 quarters · filed 2019-05-13 | $27.26M derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $6.99M derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $13.40M derived: sum of 2 quarters · filed 2019-03-18 | $18.22M derived: sum of 3 quarters · filed 2019-03-18 | $23.49M 10-K · filed 2019-03-18 |
| 2017-09-30 | $6.41M 6-K · filed 2018-11-07 | $11.24M derived: sum of 2 quarters · filed 2018-11-07 | $16.50M 6-K · filed 2018-11-07 | |
| 2017-06-30 | $4.83M 6-K · filed 2018-09-28 | $10.09M 6-K · filed 2018-09-28 | ||
| 2016-12-31 | $21.38M 20-F · filed 2018-05-14 | |||
| 2015-12-31 | $8.05M 20-F · filed 2018-05-14 |